Search results
Showing 6286 to 6300 of 8786 results
MHRA-NICE pathway opens for business – everything you need to know to get started
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.
NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments.
More than 20,000 people benefitting from innovative migraine pills recommended by NICE
A new type of tablet specifically designed to prevent migraine is transforming lives across England, with the number of people being prescribed these medicines more than tripling in just one year.
NICE publishes first quality standard to improve care for people with rare diseases
Ahead of Rare Disease Day on 28 February, we've published our first ever quality standard on rare diseases, and the first to have been developed in partnership with an external organisation.
How a collaborative taskforce is helping increase the uptake of biosimilars within the health and care sector.
Nice has recommended the first disease modifying treatment for arginase 1 deficiency (ARG1-D), an ultra-rare, inherited and progressive metabolic disorder, for routine use in the NHS in England.
How NICE guidance is accelerating access to innovative migraine treatments
Home News Podcasts How NICE guidance is accelerating access to innovative migraine treatments Podcasts 26 February 2026 Listen About this
Fertility: assessment and treatment for people with fertility problems (CG11)
This guideline has been updated and replaced by NICE guideline CG156.
Anaemia management in people with chronic kidney disease (CG114)
This guideline has been updated and replaced by NICE guideline NG8.
This guidance has been updated and replaced by NICE guideline NG129.
Ectopic pregnancy and miscarriage: diagnosis and initial management (CG154)
This guidance has been updated and replaced by NICE guideline NG126
This guidance has been updated and replaced by NICE guideline NG217.
This guidance has been updated and replaced by NICE guideline CG41.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)
This guidance has been updated and replaced by NICE guideline NG158.
Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)
This guidance has been updated and replaced by NICE guideline NG195.